Kiniksa appoints Ross Moat as COO and Eben Tessari as Chief Strategy Officer

Kiniksa Pharmaceuticals International, plc

Ross Moat promoted to COO effective Jan 10, 2026; will oversee commercial and functional operations.
Eben Tessari appointed Chief Strategy Officer effective Jan 10, 2026; adds AI initiatives to strategy and BD.
No changes to compensation for either executive in connection with the appointments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.